Dermatology Excimer Laser Market Report 2025

The dermatology excimer laser market size has grown strongly in recent years. It will grow from $0.61 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the increasing prevalence of chronic skin conditions, rising demand for targeted phototherapy, greater awareness of non-invasive treatment options, higher healthcare spending, and an expanding elderly population.

The dermatology excimer laser market size is expected to see strong growth in the next few years. It will grow to $0.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth in the forecast period can be linked to increasing demand for personalized dermatological therapies, greater adoption of outpatient laser procedures, a rise in autoimmune skin disorders, heightened focus on aesthetic skin care, and increased investments in dermatology research. Key trends expected during this time include the development of portable and handheld laser devices, real-time monitoring of skin responses, combination treatments using multiple modalities, wireless and battery-operated excimer lasers, cloud-based management of patient data, and advancements in wavelength modulation technology.

The rising prevalence of skin diseases is expected to drive growth in the dermatology excimer laser market in the coming years. Skin diseases encompass medical conditions that affect the skin’s structure or function, leading to symptoms such as rashes, inflammation, or lesions. These include psoriasis, eczema, acne, vitiligo, dermatitis, fungal infections, warts, melanoma, and alopecia. The increase in skin disease cases is linked to growing environmental pollution, which can damage the skin barrier and trigger inflammatory or allergic responses. Dermatology excimer lasers are used to manage skin diseases by delivering targeted ultraviolet B (UVB) therapy, making them particularly effective for localized conditions like psoriasis and vitiligo. These lasers reduce reliance on systemic treatments by offering precise, non-invasive care, enhancing patient comfort and treatment outcomes. For example, in 2023, Cancer Australia, a government agency, reported about 8,257 new melanoma skin cancer cases, which accounted for 2.6% of all cancer-related deaths. Hence, the increasing prevalence of skin diseases is fueling the dermatology excimer laser market’s growth.

The rising demand for minimally invasive procedures is also expected to boost the dermatology excimer laser market going forward. Minimally invasive procedures involve medical treatments conducted through small incisions or openings, which reduce patient trauma and recovery time. The preference for these procedures is increasing as patients seek quicker recovery and shorter hospital stays compared to traditional surgery. Dermatology excimer lasers contribute to minimally invasive procedures by delivering precise, targeted ultraviolet light to treat skin conditions without harming surrounding tissues. They enhance patient outcomes by shortening recovery times, minimizing side effects, and effectively treating localized lesions. For instance, in November 2024, the American Society of Plastic Surgeons reported that the total number of cosmetic minimally invasive procedures in 2023 reached 25,442,640, a 7% rise from 23,672,269 in 2022. Thus, growing demand for minimally invasive procedures is propelling the dermatology excimer laser market.

Leading companies in the dermatology excimer laser market are focusing on creating advanced products and obtaining regulatory approvals, such as modernized user interfaces, to enhance usability, precision, and treatment effectiveness. A modernized user interface typically involves an intuitive touchscreen control system that simplifies operation and increases treatment accuracy. For example, in July 2024, Strata Skin Sciences, a U.S.-based medical device company, received approval from Japan’s Ministry of Health, Labor, and Welfare for the XTRAC Momentum 1 device. This advanced excimer laser system delivers targeted UVB therapy for skin conditions like psoriasis, eczema, and vitiligo in both adults and children. The next-generation device offers greater power output and faster repetition rates than earlier models, enabling more efficient treatments. It also includes a modern touchscreen interface and a slim, ergonomic design to improve usability for clinicians and comfort for patients.

Major players in the dermatology excimer laser market are Koninklijke Philips N.V., Coherent Corp., Carl Zeiss AG, Lumenis Ltd., Cynosure LLC, Cutera Inc., Sciton Inc., Lutronic Corporation, DEKA Research & Development Corporation, Solta Medical Inc., Quanta System S.p.A., Strata Skin Sciences Inc., The Daavlin Company, Asclepion Laser Technologies GmbH, Aerolase Corporation, Kernel Medical Equipment Co. Ltd., Zimmer MedizinSysteme GmbH, Candela Corporation, Ra Medical Systems Inc., KOMACHINE Co. Ltd., PhotoMedex Inc., iVis Technologies S.r.l., Fotona d.o.o., and Wuhan Dimed Laser Technology Co. Ltd.

North America was the largest region in the dermatology excimer laser market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dermatology excimer laser report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the dermatology excimer laser market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dermatology excimer laser market consists of revenues earned by entities by providing services such as excimer laser therapy sessions, dermatological assessments for laser suitability, treatment planning and customization, follow-up and maintenance laser treatments, and patient education and support related to laser-based skin therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The dermatology excimer laser market also consists of sales of excimer laser consoles, protective eyewear, cooling systems, handpieces or delivery systems, and software updates and connectivity ports. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The dermatology excimer lasers market research report is one of a series of new reports that provides dermatology excimer lasers market statistics, including dermatology excimer lasers industry global market size, regional shares, competitors with a dermatology excimer lasers market share, detailed dermatology excimer lasers market segments, market trends and opportunities, and any further data you may need to thrive in the dermatology excimer lasers industry. This dermatology excimer lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A dermatology excimer laser is a sophisticated medical device that emits monochromatic ultraviolet B (UVB) light at a wavelength of 308 nanometers, specifically intended for therapeutic skin treatments. It delivers intense, focused light precisely to targeted areas of the skin while minimizing exposure to surrounding healthy tissue. The primary goal of this laser is to provide accurate, localized phototherapy with reduced side effects.

The main categories of dermatology excimer lasers include tabletop, handheld, and trolley-mounted models. A tabletop excimer laser is a compact, portable device designed to sit on a table or cart for use in clinical or outpatient environments. It is employed to treat various conditions such as psoriasis, vitiligo, atopic dermatitis, allergic rhinitis, alopecia areata, and more, catering to end users like hospitals, dermatology clinics, and plastic surgery centers.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.